Pospos, Jerome B.
HRN: 23-65-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
CEFTRIAXONE 1G (VIAL)
09/06/2023
09/13/2023
IVT
1gm
Q12
Fracture Open II Tibia And Fibula M/3rd Left
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes